Key PointsAn Oruka Therapeutics executive reported selling 9,854 directly held Common Stock shares for a total value of $687K based on a weighted average price of $69.72 per share as of June 15, 2026.This transaction represented 36.83% of Arjun Agarwal's direct Common Stock holdings prior to the trade, reducing his direct ownership to 16,899 shares.The disposition involved only direct holdings; no indirect entities participated, and the activity…